UPDATE
Applications to the Infected Blood Interim Estates Payment Scheme (IBIEPS) will close on 30 October.
We will make every effort to process all applications received before 30 October. However we strongly encourage you to apply as early as possible to ensure your application is processed in time.
Estates of eligible infected people can still apply for compensation under the Infected Blood Compensation Scheme. You can register your intent to claim with the Infected Blood Compensation Authority here.
After that date, estates and bereaved partners should apply directly to the Infected Blood Compensation Authority (IBCA) who are responsible for any compensation payments. You can visit their latest updates on their website.
With effect from 1 April 2025, the Wales Infected Blood Support Scheme (WIBSS) is now closed to new applications for anyone who has historically been infected with hepatitis C, HIV or both, from NHS blood or blood products.
Interim Estates Payment
Applications for interim payments to estates continue to remain open until the 30th of October and guidance on how to apply, the eligibility criteria, and the application process is available at: www.gov.uk/infected-blood-compensation-estates.
Estates Interim payments – Register your intent to claim compensation with the Infected Blood Compensation Authority
If you have received interim compensation payments as an estate representative of a deceased infected person from WIBSS and you have not yet registered your intent to make a compensation claim with the Infected Blood Compensation Authority (IBCA), then please do so using the link here – Register your intent to claim compensation – IBCA. This will ensure that IBCA knows that you would like to claim compensation as soon as IBCA is ready to take claims from estate representatives of a deceased infected person. Please note that the order in which IBCA contact people to make their claims will follow the recommendations of the Infected Blood Inquiry rather than being based on when people registered.
Please click here for Infected Blood Compensation Authority information
Clarification on tax implications of interest earned on the investment of payments and action required
Since 1988, successive governments have set up various schemes to provide financial support to individuals infected with Hepatitis C, HIV or both through NHS treatment with contaminated blood products. The longstanding position has been that such ex gratia payments should be exempt from tax.
Following the introduction of new schemes, legislation was introduced in 2017 to ensure that periodical payments to beneficiaries from those schemes were exempt from income tax, in the same way as periodical payments from existing schemes.
The exemption only extends to the periodical payments or annuities in respect of the damages. Any return from investing those sums is not exempted. Once any money received from compensation is invested any interest received on that investment will be taxable in the normal way and should be declared in tax returns and self-assessments. Independent financial advice should be sought as previously advertised.
Wales Infected Blood Support Scheme – WIBSS
Established in October 2017, the Wales Infected Blood Support Scheme (WIBSS) aims to provide support to people who have been infected with Hepatitis C and/or HIV as a result of NHS treatment with blood, blood products or tissue in Wales.
WIBSS has taken over from the UK previous schemes (Eileen Trust, Macfarlane Trust, MFET Ltd, Skipton Fund and Caxton Foundation) and aims to provide both a streamlined financial payment service, a Welfare Advice Service and a Psychology and Well-being service for Welsh beneficiaries and their families.
Welsh Government provide Directions and Regulations that WIBSS follow, all Directions and Regulation amendments can be found here.
Welsh Government has notified WIBSS of the revised rates for 2026-2027. This rate will be applicable from 1st April 2026. To see the revised rates, please click here.
Please click the link to access the current Customer Satisfaction Survey Report for WIBSS.